On March 25, 2026, 4D Molecular Therapeutics, Inc. appointed Kristian Humer as the Principal Accounting Officer, succeeding Ashoo Gupta, who remains Vice President, Finance. This change follows Mr. Humer's previous roles in biotechnology and finance, including as CFO at Foghorn Therapeutics.